TGF-β1-induced LPP expression dependant on Rho kinase during differentiation and migration of bone marrow-derived smooth muscle progenitor cells

Zhiling Qu , Jun Yu , Qiurong Ruan

Current Medical Science ›› 2012, Vol. 32 ›› Issue (4) : 459 -465.

PDF
Current Medical Science ›› 2012, Vol. 32 ›› Issue (4) : 459 -465. DOI: 10.1007/s11596-012-0080-0
Article

TGF-β1-induced LPP expression dependant on Rho kinase during differentiation and migration of bone marrow-derived smooth muscle progenitor cells

Author information +
History +
PDF

Abstract

Lipoma preferred partner (LPP) has been identified as a protein which is highly selective for smooth muscle progenitor cells (SMPCs) and regulates differentiation and migration of SMPCs, but mechanisms of LPP expression are not elucidated clearly. The aim of the present study was to discuss the mechanisms by which LPP expression is regulated in the differentiation and migration of SMPCs induced by TGF-β1. It was found that TGF-β1 could significantly increase the expression of LPP, smooth muscle α-actin, smooth muscle myosin heavy chain (SM-MHC), and smoothelin in SMPCs. Moreover, inactivation of Rho kinase (ROK) with ROK inhibitors significantly inhibited LPP mRNA expression in TGF-β1-treated SMPCs and mouse aortic smooth muscle cells (MAoSMCs). At the same time, LPP silencing with short interfering RNA significantly decreased SMPCs migration. In conclusion, LPP appears to be a ROK-dependant SMPCs differentiation marker that plays a role in regulating SMPCs migration.

Keywords

lipoma preferred partner / smooth muscle progenitor cells / differentiation / migration / Rho kinase

Cite this article

Download citation ▾
Zhiling Qu, Jun Yu, Qiurong Ruan. TGF-β1-induced LPP expression dependant on Rho kinase during differentiation and migration of bone marrow-derived smooth muscle progenitor cells. Current Medical Science, 2012, 32(4): 459-465 DOI:10.1007/s11596-012-0080-0

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

SinhaS., HoofnagleM.H., KingstonP.A., et al.. Transforming growth factor-beta1 signaling contributes to development of smooth muscle cells from embryonic stem cells. Am J Physiol Cell Physiol, 2004, 287(6): 1560-1568

[2]

BjorkerudS.. Effects of transforming growth factor-beta 1 on human arterial smooth muscle cells in vitro. Arterioscler Thromb, 1991, 11(4): 892-902

[3]

HautmannM.B., MadsenC.S., OwensG.K.. A transforming growth factor TGF-β1 control element drives TGF-β1 induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements. J Biol Chem, 1997, 272(16): 10 948-10 956

[4]

SuwanabolP.A., KentK.C., LiuB.. TGF-β and restenosis revisited: a Smad link. J Surg Res, 2011, 167(2): 287-297

[5]

ChenS., CrawfordM., DayR.M., et al.. RhoA modulates Smad signaling during transforming growth factor-b-induced smooth muscle differentiation. J Biol Chem, 2006, 281(3): 1765-1770

[6]

MaurerM.H.. Proteomic definitions of mesenchymal stem cells. Stem Cells Int, 2011, 2011(1): 1-9

[7]

VazãoH., das NevesR.P., GrãosM., et al.. Towards the maturation and characterization of smooth muscle cells derived from human embryonic stem cells. PLoS One, 2011, 6(3): e17

[8]

YuJ., RuanQ.R.. Filtrating smooth muscle progenitor cells from mouse bone marrow mesenchymal stem cells by recombinant Psm22α-EGFP-1. Chin J Pathol, 2007, 36(12): 825-831

[9]

VoE., Hanjaya-PutraD., ZhaY., et al.. Smooth-muscle-like cells derived from human embryonic stem cells support and augment cord-like structures in vitro. Stem Cell Rev, 2010, 6(2): 237-247

[10]

LouisS.F., ZahradkaP.. Vascular smooth muscle cell motility: From migration to invasion. Exp Clin Cardiol, 2010, 15(4): e75-85

[11]

LiY., YuJ., LiM., et al.. Mouse mesenchymal stem cells from bone marrow differentiate into smooth muscle cells by induction of plaque-derived smooth muscle cells. Life Sci, 2011, 88(3–4): 130-140

[12]

LiM., YuJ., LiY., et al.. CXCR4+ progenitors derived from bone mesenchymal stem cells differentiate into endothelial cells capable of vascular repair after arterial injury. Cell Reprogram, 2010, 12(4): 405-415

[13]

GrunewaldT.G., PasedagS.M., ButtE.. Cell adhesion and transcriptional activity — defining the role of the novel protooncogene LPP. Transl Oncol, 2009, 2(3): 107-116

[14]

JinL., HastingsN.E., BlackmanB.R., et al.. Mechanical properties of the extracellular matrix alter expression of smooth muscle protein LPP and its partner palladin; relationship to early atherosclerosis and vascular injury. J Muscle Res Cell Motil, 2009, 30(1–2): 41-55

[15]

JinL., GanQ., ZiebaB.J., et al.. The actin associated protein palladin is important for the early smooth muscle cell differentiation. PLoS One, 2010, 5(9): e12 823

[16]

PetitM.M., MolsR., SchoenmakersE.F., et al.. LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family. Genomics, 1996, 36(1): 118-129

[17]

BoëdaB., KnowlesP.P., BriggsD.C., et al.. Molecular recognition of the Tes LIM2–3 domains by the actin-related protein Arp7A. J Biol Chem, 2011, 286(13): 11 543-11 554

[18]

LaiY.J., LinV.T., ZhengY., et al.. The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration. Mol Cell Biol, 2010, 30(23): 5582-5596

[19]

Rolli-DerkinderenM., ToumaniantzG., PacaudP., et al.. RhoA phosphorylation induces Rac1 release from guanine dissociation inhibitor alpha and stimulation of vascular smooth muscle cell migration. Mol Cell Biol, 2010, 30(20): 4786-4796

[20]

Ford-SpeelmanD.L., RocheJ.A., BowmanA.L., et al.. The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle. Mol Biol Cell, 2009, 20(17): 3905-3917

[21]

SotiropoulosA., GineitisD., CopelandJ., et al.. Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell, 1999, 98(2): 159-169

[22]

PetitM.M., LindskogH., LarssonE., et al.. Smooth muscle expression of lipoma preferred partner is mediated by an alternative intronic promoter that is regulated by serum response factor/myocardin. Circ Res, 2008, 103(1): 61-69

[23]

ChenS., LechleiderR.J.. Transforming growth factor-β-induced differentiation of smooth muscle from a neural crest stem cell line. Circ Res, 2004, 94(9): 1195-1202

[24]

JeonE.S., MoonH.J., LeeM.J., et al.. Sphingosylphorylcholine induces differentiation of human mesenchymal stem cell into smooth muscle-like cells through a TGF-β-dependent mechanism. J Cell Sci, 2006, 119(23): 4994-5005

[25]

YuJ., LiM., QuZ., et al.. SDF-1/CXCR4-mediated migration of transplanted bone marrow stromal cells toward areas of heart myocardial infarction through activation of PI3K/Akt. J Cardiovasc Pharmacol, 2010, 55(5): 496-505

[26]

HanafusaH., Ninomiya-TsujiJ., MasuyamaN., et al.. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-b-induced gene expression. J Biol Chem, 1999, 274(38): 27 161-27 167

[27]

LiB., ZhuangL., ReinhardM., et al.. The lipoma preferred partner LPP interacts with alpha-actinin. J Cell Sci, 2003, 116(7): 1359-1366

[28]

JinL., KernM.J., OteyC.A., et al.. Angiotensin II, focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner palladin to promote cell migration. Circ Res, 2007, 100(6): 817-825

[29]

GarveyS.M., SindenD.S., Schoppee BortzP.D., et al.. Cyclosporine up-regulates Krüppel-like factor-4 (KLF4) in vascular smooth muscle cells and drives phenotypic modulation in vivo. J Pharmacol Exp Ther, 2010, 333(1): 34-42

AI Summary AI Mindmap
PDF

75

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/